
Glicrite OD 60mg/500mg Tablet ER
Marketer
Eswar Therapeutics Pvt Ltd
Salt Composition
Gliclazide (60mg) + Metformin (500mg)
Overview Glicrite OD 60mg/500mg Tablet ER
Diabetic patients using the extended-release Glicrite OD 60mg/50mg tablet, an anti-diabetic medication, should understand its dual-action mechanism for managing type 2 diabetes in adults. This combination therapy regulates blood glucose, optimally absorbed when ingested with food and consistently taken at the same time daily. Dosage adjustments, determined by your physician based on blood sugar monitoring, might be necessary. Continuous use, even with seemingly controlled blood sugar, is crucial; abrupt cessation increases the risk of complications including hyperglycemia, potentially leading to kidney damage, vision impairment, neuropathy, and limb loss. Remember, Glicrite OD is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; manage this by maintaining regular mealtimes and carrying fast-acting glucose sources. Constipation and vomiting are also possible. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other reported side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, upper respiratory infections, and weight gain. Consult your physician before starting Glicrite OD if you have type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver impairment; pre-existing heart disease also warrants discussion. Similarly, pregnant or breastfeeding individuals must seek medical advice. Regular blood glucose monitoring and periodic blood tests (evaluating blood cell counts and liver function) are recommended by your doctor.
Uses of Glicrite OD 60mg/500mg Tablet ER
Non-insulin-dependent diabetes
Major Benefits of Glicrite OD 60mg/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glicrite OD 60mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Glicrite OD 60mg/500mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Dizziness
- Diarrhea
- Upper respiratory tract infection
- Nausea
- Flatulence
- Constipation
How to use Glicrite OD 60mg/500mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glicrite OD 60mg/500mg Extended-Release tablet should be taken with a meal.
How Glicrite OD 60mg/500mg Tablet ER works:
Extended-release Gliclazide/Metformin tablets (Glicrite OD 60mg/500mg) combine two diabetes medications.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glicrite OD 60mg/500mg Extended-Release tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glicrite OD 60mg/500mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glicrite OD 60mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glicrite OD 60mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glicrite OD 60mg/500mg Extended-Release tablets are contraindicated in individuals with severe kidney disease. Kidney function should be regularly assessed during treatment.
LiverCAUTION
Patients with liver impairment should use Glicrite OD 60mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. A reduced initial dose is typically advised for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Glicrite OD 60mg/500mg Tablet ER :
Should you forget a dose of Glicrite OD 60mg/500mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glicrite OD 60mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
